Universidade Federal de Alfenas Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2019
NCT04495374
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

UNIFAL-MG | Universidade Federal de Alfenas